Gambir

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Gambir
Accession Number
DB14298
Description

Gambir is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Type
Biotech
Groups
Experimental
Synonyms
  • Catechu
  • Gambir (Uncaria Gambir)
  • Gambir Leaf
  • Nauclea Gambir Leaf
  • Ourouparia Gambir Leaf
  • Uncaria Gambir Leaf
  • Uncaria Gambir Leafy Twig
  • Uruparia Gambir Leaf

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
EdgeGambir (2 mg/1g) + Eleuthero (.124 mg/1g) + Epimedium grandiflorum top (.012 mg/1g) + Erythroxylum catuaba bark (.025 mg/1g) + Ginkgo biloba (.124 mg/1g) + Mucuna pruriens seed (.025 mg/1g) + Panax notoginseng root (.018 mg/1g) + Tribulus terrestris fruit (.124 mg/1g) + Turnera diffusa leaf (.124 mg/1g)GelTopicalAloe Vera Industries Pty Ltd2015-04-01Not applicableUS flag
EdgeGambir (2 mg/1g) + Eleuthero (.124 mg/1g) + Epimedium grandiflorum top (.012 mg/1g) + Erythroxylum catuaba bark (.025 mg/1g) + Ginkgo biloba (.124 mg/1g) + Mucuna pruriens seed (.025 mg/1g) + Panax notoginseng root (.018 mg/1g) + Tribulus terrestris fruit (.124 mg/1g) + Turnera diffusa leaf (.124 mg/1g)GelTopicalSensuous Pty Ltd2015-04-01Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
EdgeGambir (2 mg/1g) + Eleuthero (.124 mg/1g) + Epimedium grandiflorum top (.012 mg/1g) + Erythroxylum catuaba bark (.025 mg/1g) + Ginkgo biloba (.124 mg/1g) + Mucuna pruriens seed (.025 mg/1g) + Panax notoginseng root (.018 mg/1g) + Tribulus terrestris fruit (.124 mg/1g) + Turnera diffusa leaf (.124 mg/1g)GelTopicalAloe Vera Industries Pty Ltd2015-04-01Not applicableUS flag
EdgeGambir (2 mg/1g) + Eleuthero (.124 mg/1g) + Epimedium grandiflorum top (.012 mg/1g) + Erythroxylum catuaba bark (.025 mg/1g) + Ginkgo biloba (.124 mg/1g) + Mucuna pruriens seed (.025 mg/1g) + Panax notoginseng root (.018 mg/1g) + Tribulus terrestris fruit (.124 mg/1g) + Turnera diffusa leaf (.124 mg/1g)GelTopicalSensuous Pty Ltd2015-04-01Not applicableUS flag

Categories

Drug Categories
Not Available
Classification
Not classified

Chemical Identifiers

UNII
3NJQ5D8S6N
CAS number
8001-48-7

References

General References
Not Available
RxNav
1609190
Wikipedia
Gambir

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedSupportive CareGingivitis1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
GelTopical
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on July 05, 2018 11:13 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates